Regulation of eicosanoid pathways: A pathway to health and development

Pakistan Journal of Nutrition

Volumn 1, Issue 2, 2002, Pages 103-105

  Cook, Mark E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2042545282     PISSN: 16805194     EISSN: None     Source Type: Journal    
DOI: 10.3923/pjn.2002.103.105     Document Type: Review

References (38)

1. 2. Annu. Rev. Pharmacol. Toxicol., 39:175-189.
2. Belury, M.A., K.P. Nickel, C.E. Bird and Y.M. Wu, 1996. Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr. Cancer, 26:149-157.
3. Chin, S.F., W. Liu, J.M. Storkson, Y.L. Ha and M.W. Pariza, 1992. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J. Food Compos. Anal., 5:185-197.
4. Chin, S.F., J.M. Storkson, K.J. Albright, M.E. Cook and M.W. Pariza, 1994. Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J. Nutr., 124:2344-2349.
5. Cook, M.E., C.C. Miller, Y. Park and M. Pariza, 1993. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poult. Sci., 72:1301-1305.
6. Cook, M.E. and D.L. Jerome, 1998. Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein. US Patent, 5,725,873.
7. Cook, M.E., C.C. Miller and J.L. Pimentel, 1998a. Novel compound to mimic a naturally occurring peptide effect. U.S. Patent, 5,814,316.
8. Cook, M.E., C.C. Miller, and J.L. Pimentel, 1998b. CCK antibodies used to improve feed efficiency. US Patent, 5,827,517.
9. Cook, M.E. and M.W. Pariza, 1998. The role of conjugated linoleic acid (CLA) in health. Int. Dairy J., 8:459-462.
10. Cook, M.F., Cheryl C. Miller and Julio L. Pimentel, 1999. CCK antibodies used to improve feed efficiency. U.S. Patent 5,989,584.
11. Cook, M.E., 1999. Nutritional Effects on Vaccination. In: Veterinary Vaccines and Diagnostics (ed. R. D. Schultz). Advances in Vet. Med., Vol. 41: 53-59.
12. Cook, M. F., 2001. Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency. U. S. Patent, 6,213,930 B1.
13. Forman, B. M., P. Tontonoz, J. Chen, R. P. Brun, B. M. Spiegelman and R. M. Evans, 1995. 15-deoxy-delta 12, 14-prostaglandin J2 is a ligand for adipocyte determination factor PPAR gamma. Cell, 83:803-812.
14. Hanse Petrik, M. B., M. F. McEntee, B. T. Johnson, M. G. Obukowicz and J. Whelan, 2000. Highly unsaturated (n-3) fatty acids, but not (alpha)-linolenic, conjugated linoleic or (gamma)-linolenic acids, reduce tumorigenesis in AFCmin/+ mice. J. Nutr., 130:2434-2443.
15. Hwang, D., 1989. Essential fatty acids and immune response. Fed. Am. Soc. Exp. Biol. J., 3:2052-2061.
16. Ip, C., S.F. Chin, J.A. Scimeca and M.W. Pariza, 1991. Mammary cancer prevention by conjugated dienoic derivative of linoleic acid. Cancer Res., 51:6118-6124.
17. Ip, C., J.A. Scimeca and H.J. Thompson, 1994, Conjugated linoleic acid. A powerful anticarcinogen from animal fat sources. Cancer, 74:1050-1054.
18. Ip, C., J.A. Scimeca and H. Thompson, 1995. Effect of timing and duration of dietary conjugated linoleic acid on mammary cancer prevention. Nutr. Cancer, 24:241-247.
19. Lee, K.N., D. Kritchevsky and M.W. Pariza, 1994. Conjugated linoleic acid and atherosclerosis in rabbits. Atherosclerosis, 108:19-25.
20. Lev, M., and M. Forbes, 1959. Growth response to dietary penicillin of germ-free chicks with a defined intestinal flora. Br. J. Nutr., 13:78-84.
21. Liew, C., H.A.J. Schut, S.F. Chin, M.W. Pariza and R.H. Dashwood, 1995. Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4,5-f] quinoline-induced colon carcinogenesis in the F344 rat - a study of inhibitory mechanisms. Carcinogenesis, 16:3037-3043.
22. Liu, C. H., S. H. Chang, K. Narko, O. C. Trifan, M. T. Wu, E. Smith, C. Haudenschild, T. F. Lane and T. Hla, 2002. Over-expression of cyclooxygenase (COX-2) is sufficient to induce tumorgenesis in transgenic mice. J. Biol. Chem., in press.
23. Marnett, L. J., 1992. Asprin and the of prostaglandins in cancer. Cancer Res., 52:5575-5589.
24. Miller, C.C., Y. Park, M.W. Pariza and M.E. Cook, 1994. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem. Biophys. Res. Commun, 198:1107-1112.
25. Myers, L. K., A. H. Kang, A. E. Postlethwaite, E. F. Rosloniec, S. G. Morham, B. V. Shlopov, S. Goorha and L. R. Ballou, 2000. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheumatism, 43:2687-2693.
26. Nicolosi, R.J., E.J. Rogers, D. Kritchevsky, J.A. Scimeca and P.J. Huth, 1997. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery., 22:266-277.
27. Pariza, M.W., Y. Park and M. E. Cook, 1999. Conjugated linoleic acid and the control of cancer and obesity. Toxicol. Sci., 52(Suppl.):107-110.
28. Park, Y., J.K. Albright, W. Liu, J.M. Storkson, M.E. Cook and M.W. Pariza, 1997. Effect of conjugated linoleic acid on body composition in mice. Lipids, 32:853-858.
29. Riendeau, D., M. D. Percival, C. Brideau, S. Charleson, D. Dube, D. Bhier, J. P. Falgueyret, R. W. Frisen, R. Gordon, G. Grieg, J. Guay, J. Mancini, M. Ouellet, E. Wong, L. Xu, S. Boyce, D. Visco, Y. Girard, P. Prasit, R. Zamboni, I. W. Roder, M. Gresser, A. W. Ford-Hutchinson, R. N. Young and C. C. Chan, 2001. Etoricoxib (MK-0663): Preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J. Pharma. Exptl. Thera., 296:558-566.
30. Sessler, A. M. and J. M. Ntambi, 1998. Polyunsaturated fatty acid regulation of gene expression. J. Nutr., 128:923-926.
31. Sugano, M., A. Tsujita, M. Yamasaki, K. Yamada, I. Ikeda and D. Kritchevsky, 1997. Lymphatic recovery, tissue distribution, and metabolic effects of conjugated linoleic acid in rats. J. Nutr. Biochem., 8:38-43.
32. Sugano, M., A. Tsujita, M. Yamasaki, M. Noguchi and K. Yamada, 1998. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids, 33:521-527.
33. Thun, M. J., M. N. Nambooodiri, E. Calle, W. D. Flanders and C. W. Heath, Jr., 1993. Aspirin use and risk of fatal cancer. Cancer Res., 53:1322-1327.
34. Van Wauwe, J. and J. Goossens, 1983. Effects of antioxidants on cyclooxygenase and lipoxygenase activities in intact human platelets. Prostaglandins, 26:725-730.
35. Visonneau, S., A. Cesano, S.A. Tepper, J.A. Scimeca, D. Santoli and D. Kritchevsky, 1997. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in scid mice. Anticancer. Res., 17:969-973.
36. Whigham, L. D., E. B. Cook, J. L. Stahl, R. Saban, D. E. Bjorling, M. W. Pariza and M. E. Cook, 2001. CLA reduces antigen-induced histamine and PGE release from sensitized guinea pig trachea. Am. J. Physiol. Regulatory Integrative Comp. Physiol., 280:908-912.
37. Whigham, L. D., A. Higbee, D. E. Bjorling, Y. Park, M.W. Pariza and M. E. Cook, 2002. Conjugated linoleic acid reduces anti-induced prostaglandin and luekotriene release from sensitized guinea pig lung trachea, and bladder as measured by HPLC-tandem mass spectrometry. Am. J. Physiol. Regulatory. Integrative Comp. Physiol., In press.
38. Yang, M., M. W. Pariza and M. E. Cook, 2000. Conjugated linoleic acid protects against end stage disease of systemic lupus erythematosus in the NZB/W F1 mouse. Immunopharma. Immunotox., 22:433-44.